ProfessorTimothyHallett

Faculty of Medicine, School of Public Health

Professor of Global Health

Contact

Location

School of Public HealthWhite City Campus

Summary

I am an Associate Director of the MRC Centre for Global Infectious Disease Analysis and a lead investigator at the Jameel Institute.

My main research interests are:

Characterising the epidemiology of, and the potential impact of interventions for, some of the most high burden infectious diseases globally (e.g. for HIV, HBV, HCV, TB);
Understanding how resources available for healthcare systems can be used to generate the greatest health gains for the population they serve (see tlomodel.org);

Formerly, I have founded and directed the HIV Modelling Consortium (a network of epidemiologists, statisticians and health-economists focussed on HIV in the highest burden settings) and chaired the UNAIDS Reference Group on Estimates, Modelling and Projections (which reviews and develops the official methods for calculating AIDS statistics). In many areas, I have worked closely with the Manicaland Centre for Public Health Research.

I am also an Affiliate Professor at the University of Washington, Department of Global Health, chair of the Modelling Guidance Group of The Global Fund and a Fellow of the Academy of Medical Sciences.

I teach on the on-campus MSc Epidemiology and MPH programs and direct the Global Disease Masterclass module of the (online) Global MPH.

Selected Publications

Journal Articles

Whittaker C, Watson O, Alvarez-Moreno C, et al.Whittaker C, Watson O, Alvarez-Moreno C, Angkasekwinai N, Boonyasiri A, Triana LC, Chanda D, Charoenpong L, Chayakulkeeree M, Cooke G, Croda J, Cucunubá ZM, Djaafara A, Estofolete CF, Grillet M-E, Faria N, Costa SF, Forero-Peña DA, Gibb DM, Gordon A, Hamers RL, Hamlet A, Irawany V, Jitmuang A, Keurueangkul N, Kimani TN, Lampo M, Levin A, Lopardo G, Mustafa R, Nayagam AS, Ngamprasertchai T, Njeri NIH, Nogueira ML, Ortiz-Prado E, Perroud Jr. MW, Phillips AN, Promsin P, Qavi A, Rodger AJ, Sabino EC, Sangkaew S, Sari D, Sirijatuphat R, Sposito AC, Srisangthong P, Thompson H, Udwadia Z, Valderrama-Beltrán S, Winskill P, Ghani A, Walker P, Hallett T close, 2022, Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis, Clinical Infectious Diseases, Vol:75, ISSN:1058-4838, Pages:e224-e233

Hogan A, Jewell B, Sherrard-Smith E, et al.Hogan A, Jewell B, Sherrard-Smith E, Watson O, Whittaker C, Hamlet A, Smith J, Winskill P, Verity R, Baguelin M, Lees J, Whittles L, Ainslie K, Bhatt S, Boonyasiri A, Brazeau N, Cattarino L, Cooper L, Coupland H, Cuomo-Dannenburg G, Dighe A, Djaafara A, Donnelly C, Eaton J, van Elsland S, Fitzjohn R, Fu H, Gaythorpe K, Green W, Haw D, Hayes S, Hinsley W, Imai N, Laydon D, Mangal T, Mellan T, Mishra S, Parag K, Thompson H, Unwin H, Vollmer M, Walters C, Wang H, Ferguson N, Okell L, Churcher T, Arinaminpathy N, Ghani A, Walker P, Hallett T close, 2020, Potential impact of the COVID-19 pandemic on HIV, TB and malaria in low- and middle-income countries: a modelling study, The Lancet Global Health, Vol:8, ISSN:2214-109X, Pages:e1132-e1141

Reid MJA, Arinaminpathy N, Bloom A, et al.Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP close, 2019, Building a tuberculosis-free world: The Lancet Commission on tuberculosis, The Lancet, Vol:393, ISSN:0140-6736, Pages:1331-1384

Heffernan A, Cooke GS, Nayagam S, et al.Heffernan A, Cooke GS, Nayagam S, Thursz M, Hallett TB close, 2019, Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model., The Lancet, Vol:393, ISSN:0140-6736, Pages:1319-1329

McGillen JB, Sharp A, Honermann B, et al.McGillen JB, Sharp A, Honermann B, Millett G, Collins C, Hallett TB close, 2017, Consequences of a changing US strategy in the global HIV investment landscape., AIDS, Vol:31, ISSN:0269-9370, Pages:F19-F23

Nayagam S, Conteh L, Sicuri E, et al.Nayagam S, Conteh L, Sicuri E, Shimakawa Y, Lemoine M, Hallett TB, Thursz M close, 2016, Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa - Authors' reply., Lancet Global Health, Vol:5, ISSN:2214-109X, Pages:e35-e35

Nayagam S, Thursz M, Sicuri E, et al.Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D, Hallett TB close, 2016, Requirements for global elimination of hepatitis B: a modelling study, Lancet Infectious Diseases, Vol:16, ISSN:1473-3099, Pages:1399-1408

Eaton JW, Bacaer N, Bershteyn A, et al.Eaton JW, Bacaer N, Bershteyn A, Cambiano V, Cori A, Dorrington RE, Fraser C, Gopalappa C, Hontelez JAC, Johnson LF, Klein DJ, Phillips AN, Pretorius C, Stover J, Rehle TM, Hallett TB close, 2015, Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral therapy era, Lancet Global Health, Vol:3, ISSN:2214-109X, Pages:e598-e608

Anderson S-J, Cherutich P, Kilonzo N, et al.Anderson S-J, Cherutich P, Kilonzo N, Cremin I, Fecht D, Kimanga D, Harper M, Masha RL, Ngongo PB, Maina W, Dybul M, Hallett TB close, 2014, Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study, The Lancet, Vol:384, ISSN:0140-6736, Pages:249-256

Eaton JW, Menzies NA, Stover J, et al.Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JAC, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Baernighausen T, Bershteyn A, Bloom DE, Boily M-C, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DAMC, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB close, 2014, Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models, The Lancet Global Health, Vol:2, ISSN:2214-109X, Pages:E23-E34

Hallett TB, Menzies NA, Revill P, et al.Hallett TB, Menzies NA, Revill P, Keebler D, Borquez A, McRobie E, Eaton JW close, 2014, Using modeling to inform international guidelines for antiretroviral treatment, AIDS, Vol:28, ISSN:0269-9370, Pages:S1-S4

Hallett TB, Eaton JW, 2013, A Side Door Into Care Cascade for HIV-Infected Patients?, JAIDS - Journal of Acquired Immune Deficiency Syndromes, Vol:63, ISSN:1525-4135, Pages:S228-S232

Author Web Link

HIV Modelling Consortium Treatment as Prevention Editorial Writing Group, 2012, HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making., PLOS Medicine, Vol:9, ISSN:1549-1277

More Publications